This infographic provides a visual overview of the main points from the FIDELIO-DKD study
This infographic outlines the importance of urine albumin creatinine ratio (UACR) testing and monitoring of kidney function, along with pharmacotherapy options for the management of DKD
This dosing card provides details on initiating treatment with Kerendia, dose adjustment and monitoring requirements
This download clearly outlines a Kerendia patient and concise dosing guidelines
Alternatively, open your phone camera application, hold it over the QR code and tap the link that appears.
PP-KER-GB-0526 | September 2023
The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Copyright 2023 Oxbridge Solutions Ltd®. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions Ltd® receives funding from advertising but maintains editorial independence. GPnotebook stores small data files on your computer called cookies so that we can recognise you and provide you with the best service. If you do not want to receive cookies please do not use GPnotebook.
Are you a Great Britain healthcare professional?
The information is intended for Great Britain healthcare professionals only.
Please confirm below.
You are leaving GP Notebook
GP Notebook is not responsible for content hosted on third party websites.
Tirzepatide is recommended for treating type 2 diabetes alongside diet and exercise in adults when it is insufficiently controlled only if:
Use lower BMI thresholds (usually reduced by 2.5 kg/m2) for peoplefrom South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family backgrounds.
Reference: 10. © NICE 2023 Tirzepatide for treating type 2 diabetes. Available from https://www.nice.org.uk/
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.